GL1X · GenesisL1 explorer

MolNFT v1 · #153691 · protein

Crystal structure of human dhodh in complex with inhibitor 0946

6JME · Dihydroorotate dehydrogenase (quinone), mitochondrial: “Crystal structure of human dhodh in complex with inhibitor 0946”. X-ray diffraction, 5 ligands (FMN, ORO, BVU), 5 pockets (best druggability 0.84). MolNFT v1 #153691 on…

PDB
6JME
Type
protein
Length
365 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydroorotate dehydrogenase (quinone), mitochondrial
EC
1.3.5.2
UniProt
Q02127
Ligands
FMN, ORO, BVU, NA, SO4
Pockets
5 · best druggability 0.84

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydroorotate dehydrogenase (quinone), mitochondrial (EC 1.3.5.2)protein36547% helix, 16% strandQ02127

Ligands and binding sites

  • FMN · Flavin mononucleotide · ligand · chains A
  • ORO · Orotic acid · ligand · chains A
  • BVU · 3-[3,5-bis(fluoranyl)-4-(2-fluorophenyl) phenyl]benzo[f]benzotriazole-4,9-dione · ligand · chains A
  • NA · Sodium ion · metal · 3 copies · chains A
  • SO4 · Sulfate ion · ion · 3 copies · chains A
  • ACT · Acetate ion · additive · 3 copies · chains A
  • LDA · Lauryl dimethylamine-N-oxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13950.840.9258FMN, ORO, BVU
2620.500.8614empty
3970.440.8019ACT
4820.400.7919ACT, NA
5560.310.7617empty

Compared structures

  • 6JME · Crystal structure of human DHODH in complex with inhibitor 0946 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.